Scaling AI Projects Multiplies Returns

Boost Your ROI: Scaling AI Projects Multiplies Returns

Successfully scaling generative AI projects can significantly boost your ROI. While initial returns from pilot projects may be limited, scaling these initiatives can yield three times the return compared to those that never move beyond the pilot stage. For every dollar invested in AI, companies see an average return of $3.5, with most deployments taking 12 months or less to show results.

To truly maximize your ROI, it’s essential to move from pilots to full-scale deployment. Nearly a third of all AI pilot initiatives are eventually scaled, leading to substantial financial and operational benefits. By committing to scaling, organizations unlock the full potential of AI, transforming early experiments into powerful, value-driving systems.

Unlocking ROI Potential with FFI-Ventures

Scaling generative AI projects effectively requires not only commitment but also the right tools and expertise. This is where FFI-Ventures comes in. We offer a comprehensive suite of tools designed to help organizations identify, prioritize, and execute on generative AI use cases, ensuring that your resources are invested where they will generate the most significant return.

Our proven ROI framework supports pharmaceutical companies and other industries in making informed decisions about where to direct their AI efforts. We focus on ensuring that each initiative balances business impact, technical feasibility, and potential ROI, guiding you from the initial pilot stages through to full-scale deployment.

By partnering with FFI-Ventures, you gain access to expertise and resources that streamline the scaling process, allowing you to pull through your most promising generative AI use cases. This strategic approach not only maximizes your ROI but also accelerates your journey to becoming a leader in AI-driven innovation.

FFI-Ventures offers a wide range of tools to identify, prioritize and pull-through generative use cases, including a proved ROI-framework.

We’re supporting pharmaceutical companies making informed decisions about where to invest their AI resources, ensuring they focus on use cases that offer the best balance of business impact, technical feasibility, and potential ROI.

Why FFI-Ventures?

  • With extensive experience in Pharma & Medical Affairs, FFI deeply understands the unique challenges and requirements of Medical Affairs teams.
  • FFI combines its generative AI expertise with an in-house agency, ensuring solutions are tailored to your specific needs and grounded in real-world practicality.
  • Proven Track Record as FFI has successfully implemented private generative AI solutions for numerous healthcare companies, demonstrating its ability to drive tangible results and return on investment.

Generative AI is here to stay! By partnering with FFI, you’ll gain a trusted ally with the expertise to unlock the full potential of this transformative technology, empowering your organization to deliver exceptional value to healthcare professionals and patients alike. Reach out to us!

About OneRay.ai

OneRay.ai is a second-generation, bespoke generative AI solution co-created with medical affairs teams, incorporating a comprehensive set of features tailored to the unique needs within Pharma. Developed through close collaboration and iterative feedback loops, this platform offers a wide array of functionalities highly relevant to medical affairs professionals, such as automated literature summarization, medical content generation, validated data integration from internal and external sources, and specialized features such a medical key messages and behaviour change integration for engaging healthcare professionals and patients compliantly.